Pulse Explorar nav.journalClub Debates Tendencias Investigadores Revistas

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Cost-Effectiveness Analysis of Lung Cancer Screening in the United States | Synapse

November 5, 2019

Ver artículo completo

Cost-Effectiveness Analysis of Lung Cancer Screening in the United States

SCSteven D. CrissBoston Children's Hospital PCPianpian CaoPurdue University West Lafayette MBMehrad BastaniJohnson & Johnson (United States)

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

CISNET (Cancer Intervention and Surveillance Modeling Network) Lung Group, National Cancer Institute.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Criss et al. (Tue,) studied this question.

synapsesocial.com/papers/69dd393c99c691022d99b72a https://doi.org/https://doi.org/10.7326/m19-0322

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Population impact of lung cancer screening in the United States: Projections from a microsimulation model2018 · 27 citations
2Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking—A modelling study2018 · 74 citations
3Untitled2017 · 10 citations
4Multistage Carcinogenesis and Lung Cancer Mortality in Three Cohorts2005 · 113 citations
5Trends in Adherence to Recommended Cancer Screening: The US Population and Working Cancer Survivors2012 · 44 citations